Elicitation of biological responses by estrogen in target tissues requires the presence of ER as well as receptor-active ligand in the local microenvironment. Though much attention has been devoted to the study of the receptor in estrogen target tissues, the concept is emerging that tissue estrogen sensitivity may also be regulated by ligand availability through metabolic transformation in situ. Here, we show that targeted disruption, in the mouse, of an estrogen metabolic enzyme, estrogen sulfotransferase (EST), causes structural and functional lesions in the male reproductive system. EST catalyzes the sulfoconjugation and inactivation of estrogen and is expressed abundantly in testicular Leydig cells. Although knockout males were fertile and phenotypically normal initially, they developed age-dependent Leydig cell hypertrophy/hyperplasia and seminiferous tubule damage. Development of these lesions in the testis could be recapitulated by exogenous E2 administration in younger knockout mice, suggesting that they arose in older knockout mice from chronic estrogen stimulation. Older knockout mice were also found to have reduced testis and epididymis weights but increased seminal vesicle/coagulating gland weight because of tissue swelling. Furthermore, total and forward sperm motility of older knockout mice was reduced by 60% and 80%, respectively, and these mice produced smaller litters compared with age-matched wild-type males. These findings establish a role for EST in the male reproductive system and indicate that intracrine and paracrine estrogen activity can be modulated by a ligand transformation enzyme under a physiological setting. Thus, inhibition of estrogen metabolic enzymes by environmental chemicals, as has been demonstrated recently for the human EST, may constitute a novel mechanism of endocrine disruption in vivo. (Endocrinology 142: 5342-5350, 2001) 
lated by exogenous E2 administration in younger knockout mice, suggesting that they arose in older knockout mice from chronic estrogen stimulation. Older knockout mice were also found to have reduced testis and epididymis weights but increased seminal vesicle/coagulating gland weight because of tissue swelling. Furthermore, total and forward sperm motility of older knockout mice was reduced by 60% and 80%, respectively, and these mice produced smaller litters compared with age-matched wild-type males. These findings establish a role for EST in the male reproductive system and indicate that intracrine and paracrine estrogen activity can be modulated by a ligand transformation enzyme under a physiological setting. Thus, inhibition of estrogen metabolic enzymes by environmental chemicals, as has been demonstrated recently for the human EST, may constitute a novel mechanism of endocrine disruption in vivo. (Endocrinology 142: 5342-5350, 2001) E STROGEN IS A pleiotropic hormone that is now recognized to play important roles in many physiological processes in addition to reproduction (1, 2) . Elicitation of biological responses in estrogen target cells requires the presence of estrogen receptors and receptor-active ligand (1, 2) . Ligand availability may be determined by systemic estrogen level as well as by the equilibrium between local estrogen biosynthesis and metabolism. The significance of local estrogen biosynthesis has been well appreciated. For example, manipulation of local estrogen biosynthesis through inhibition of the estrogen biosynthetic enzyme, P450 aromatase, has been pursued as a potential therapeutic strategy for estrogen-dependent tumors (3, 4) . On the other hand, the relevance of estrogen metabolic enzymes in regulating tissue estrogen sensitivity under a physiological setting has not been adequately studied.
Among the various metabolic routes, sulfation has been recognized for many years as a prominent pathway for estrogen transformation in vivo (5, 6) . Sulfated estrogen has diminished receptor-binding affinity and is more watersoluble. Although sulfation is generally regarded as a metabolic process, the observation that, in some species, estrogen sulfate actually circulates in the blood at levels higher than that of the parent hormone suggests that estrogen sulfate may not be produced merely for the purpose of excretion (5, 6) . Because estrogen sulfate can be hydrolyzed to release the active hormone, it may exist in the blood as a reservoir for expeditious production of active estrogen in target tissues (5, 6) . Irrespective of its role in systemic estrogen homeostasis, in vitro experiments have suggested that sulfation may represent a physiologic mechanism to regulate local estrogen activity in target tissues (7) (8) (9) .
To test this hypothesis, we have chosen to study the male reproductive system of the mouse as a model. In earlier studies, we have shown that an estrogen-specific sulfotransferase (EST) is expressed abundantly in the Leydig cells of the mouse testis (10 -12) . Because testis is a major source of estrogen biosynthesis in the males (13) (14) (15) (16) (17) (18) , and several tissues within the male reproductive system are established estrogen target sites (19 -22) , we speculated that Leydig cell EST may act as a molecular switch to modulate the intracrine and paracrine activity of the locally produced estrogen. In this study, we have generated an EST-deficient mouse through targeted disruption of the EST gene and characterized the phenotype of the male reproductive system of the mutant mouse. We found that EST knockout male mice developed age-dependent structural and functional lesions in their reproductive systems because of increased local estrogen activity. This finding provides direct evidence for a physiological role of estrogen metabolism in intracrine and paracrine estrogen regulation. It also implies that inhibition of estrogen transformation enzymes by environmental chemicals, as has been shown recently for the human EST (23, 24) , may constitute a novel mechanism of endocrine disruption in vivo that is independent of their direct interaction with the estrogen receptors (25) .
Materials and Methods Animals
The use and experimentation of animals in this study was approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania.
Construction of targeting vector
To clone the mouse EST gene, a 129J/Sv FixII murine genomic library (Stratagene, La Jolla, CA) was screened, with the full-length mouse EST cDNA as a probe (10) . The mouse EST gene was found to consist of eight exons (unpublished results). A 13-kb genomic clone, containing exon II to VII, was chosen for targeting vector construction. In the first step, a cassette containing the herpes simplex virus-thymidine kinase gene under the control of the mouse phosphoglycerate kinase-1 gene promoter was excised from the pPNT vector (26) at the unique HindIII and EcoRI sites and was subcloned into pCDNA3 vector (Invitrogen, Carlsbad, CA). This was followed by insertion of the 13-kb EST gene fragment at the NotI site of pCDNA3. Finally, a neo gene cassette (NEO) containing the SV40 gene promoter was amplified by PCR from the pKO vector (Stratagene) using primers containing a KpnI site, cloned into the TA vector (Invitrogen), and then inserted into exon III of the EST gene fragment at a unique KpnI site (Fig. 1A) .
Generation of EST-deficient mice
The targeting vector was linearized by XhoI digestion and transfected into TL-1 embryonic stem (ES) cells (kindly provided by Dr. P. Laboski, University of Pennsylvania) by electroporation. This procedure and the subsequent colony screening were carried out as previously described (27) . Genomic DNAs of ES cells were digested with XbaI and screened by Southern blot analysis using a 300-bp probe 5Ј to the targeting sequence (in the 5Ј flanking region of the gene, Fig. 1A ). In this screening scheme, the wild-type (WT) EST gene produced a 6-kb XbaI band, whereas the targeted allele was expected to show a 7-kb band attributable to incorporation of the neo gene (Fig. 1A) . Confirmation hybridization on positive clones was subsequently carried out by using the neo cDNA as a probe. Targeted ES cell clones were injected into C57BL/6 mouse blastocyst to produce chimeric mice (28) . Germline transmission of the targeted gene was established by coat color (agouti) of the progeny from the matings between male chimeric mice and normal C57BL/6 female mice. Heterozygous EST knockout mice (F1 generation) were intercrossed, and the genotypes of their offspring were determined by Southern blot analysis of XbaI digested tail DNA (26, 27) . Phenotypic characterization was carried out by using mice of the F2 (first generation of homozygous knockout) or F3 generation that had a mixed 129/B6 background.
Northern and Western blot analysis and enzyme activity assays
Total RNAs from mouse testes were isolated using the TRIzol Reagent (Life Technologies, Inc., Gaithersburg, MD). RNA samples (10 g each lane) were separated on a 1.0% formaldehyde-agarose gel and transferred onto a nylon membrane (Hybond-N; Amersham Pharmacia Biotech, Arlington Heights, IL) via capillary action overnight in 5ϫ saline sodium citrate. Membranes were cross-linked under UV light and hybridized with a 32 P-labeled full-length mouse EST cDNA probe synthesized with random primers (10) . For Western blot analysis and enzyme activity assays, whole testes were homogenized in 10 vol PBS. The homogenate was centrifuged at 5000 ϫ g for 30 min, and supernatant was collected. Total protein samples were electrophoresed on 10% SDSpolyacrylamide gels (20 g per lane), transferred onto nitrocellulose membranes (Schleicher & Schuell, Inc., Keene, NH; BA85, 0.45 m), and probed with purified EST antiserum as previously described (10) . Sulfotransferase activity was measured with 3 H-labeled E2 ( [2, 4, 6, H(N)]-E2, 87.6 Ci/mmol, NEN Life Science Products (Boston, MA), final concentration 1.2 nm) in 200 l 200-mm Tris-acetate buffer, pH 7.9, containing 10 mm Mg-acetate, 1.25% Triton X-100, 100 m 3Ј-phosphoadenosine 5Ј-phosphosulfate, and an appropriate amount of cell lysates. The reaction was initiated by the addition of substrate and continued for 30 min at 37 C. The reaction mixture was extracted with 2 vol dichloromethane, and aliquot of the aqueous phase was counted and taken as a measure for amount of sulfated products (10) .
Steroid measurement and fertility test
Blood was obtained by tail vein bleeding or through cardiac puncture. Serum T and E2 levels were measured with RIA kits by following the manufacture's instructions (Diagnostic Systems Laboratories, Inc., Webster, TX). To assess the knockout mouse fertility, 4 mating experiments were performed. In the first experiment, 5 mating pairs of 2-month-old WT and knockout mice were set up, and their litter and pup numbers were recorded for 6 months. In the second experiment, 6 WT and 6 knockout males were mated for 2 months with 8-wk-old WT C57BL/6 females (The Jackson Laboratory, Bar Harbor, ME). For this experiment, each male was housed with four females in a cage. In the third mating experiment, 15 WT and 15 knockout females were mated for 2 months with 8-wk-old WT B6/D2 F1 males. The females were divided into 4 mating cages (4, 4, 4, 3) , with each cage containing 1 male mouse. In the fourth mating experiment, 5 WT and 5 knockout males, between 17-18 months old, were mated with 8-wk-old WT C57BL/6 females (The Jackson Laboratory) for 2 months. In this experiment, each male was housed with 2 females in a cage.
Histology and immunohistochemistry
Testes were harvested from age-matched WT and knockout mice. In some experiments, 2-month-old WT and knockout mice were treated with exogenous estrogen for 3 wk (10 g, 3-wk release E2 pellet, sc; Innovative Research of America, Sarasota, FL), and testes were collected. Tissues were fixed in cold Bouin's solution for 24 -72 h. They were then dehydrated and paraffin-embedded. Sections of the embedded testes were made at 5 m, and the slides were processed either for conventional hematoxylin and eosin staining or for immunohistochemistry. The later procedure was carried out using the Vectastain ABC Elite kit from Vector Laboratories, Inc. (Burlingame, CA) and a rabbit polyclonal antimouse EST antibody, as previously described. (11) .
Sperm motility assays
Sperm were collected from caudal epididymides and placed in Hanks' medium containing 2 mg/ml BSA. They were kept at 37 C until being examined microscopically. Sperm total and forward motility were determined visually on a computer screen by phase contrast microscopy. For each sperm sample, at least 10 viewing fields, each containing 20 -40 sperm, were counted. Total sperm motility was defined as clear head and flagellar movement, whereas only progressive sperm movement was counted as forward motility.
Results

Generation of EST knockout mice
Our strategy for inactivating the EST gene is illustrated in Fig. 1A . Insertion of the neo gene cassette into exon III was expected to disrupt the coding frame of the EST gene and yield a nonfunctional protein. The successful generation of homozygous EST-deficient mice was shown first by Southern blot analysis of tail DNAs. As can be seen in Fig. 1B , WT (ϩ/ϩ) mouse DNA produced a single 6-kb XbaI band; whereas in heterozygous EST knockout mice (ϩ/Ϫ), a 7-kb band (attributable to 1-kb neo gene cassette insertion), as well as the 6-kb band, was observed. In homozygous EST knockout mice (Ϫ/Ϫ), only the 7-kb band was detected, indicating that both alleles of the EST gene had been mutated (Fig. 1B) . The genotypes of offspring from heterozygous mating displayed a characteristic Mendelian distribution (of 105 mice examined, 26 were WT, 52 were heterozygous, and 27 were nullizygous). There was also no gender bias, with 13 of the 27 nullizygotes being males.
To confirm that the EST gene had been functionally inactivated and to investigate whether anomalous EST mRNA and protein (attributable to added neo sequence in exon III) had been produced, Northern and Western blot analyses and EST enzyme activity assays of testicular homogenate were performed. As shown in Fig. 2 , A and B, whereas both EST mRNA and protein were detected in the testis of WT mice as expected, no mRNA or protein of either normal or aberrant size could be detected in the knockout mice. Similarly, E2-sulfating activity was detected in the testis homogenate of WT but not that of nullizygous mice (Fig. 2C) . Immunohistochemical analysis also confirmed that EST expression in Leydig cells is disrupted (Fig. 2, D 
and E).
Because testis was the only tissue known, at the time, to express easily detectable amounts of EST, we focused our initial attention in phenotype characterization on the male reproductive system. Subsequently, we discovered that EST is also expressed in the epididymal fat pad of male mice and in late-stage mouse placenta (gestation d 12-19) and pregnant uterus (gestation d 18 and 19, unpublished observation). Preliminary studies showed that epididymal fat index was increased and that female fertility was reduced in the EST knockout mice. These putative phenotypes are being further characterized and will be described separately. Studies of the reproductive systems of knockout males revealed no apparent functional abnormalities in mice of 3-6 months of age. There were no statistical differences in serum T and free E2 levels between WT and knockout males [T: 2.00 Ϯ 3.46 ng/ml (range,
In an initial controlled mating experiment involving five breeding pairs each of WT and knockout mice, the overall fertility of the knockout pairs was found to be reduced (Table 1) . However, subsequent cross-breeding experiments suggested that the reduced fertility is most likely caused by an uncharacterized impairment in the female reproductive function (Table 1) .
Knockout mouse developed age-dependent Leydig cell hypertrophy/hyperplasia and seminiferous tubule damage
Histological examination of testes from 2-month-old mice (n ϭ 5 for each genotype) revealed no gross morphological difference between WT and knockout animals, either in the appearance and apparent number of Leydig cells or in the structural integrity of the seminiferous tubules (data not shown). In contrast, when mice of 12 months or older (n ϭ 10 for each genotype) were examined, abnormal structural changes were commonly seen in testes of the knockout mice (about 70% of the sections) but much less frequently in the WT mice (about 10% of the sections). The most prominent abnormalities were the presence of numerous hypertrophic/ hyperplastic Leydig cells in the mutant mouse testes (Fig. 3) . Unlike normal Leydig cell clusters, which were composed of 10 -20 cells of similar size that stained prominently with eosin (Fig. 3, A and C) , masses of hypertrophic Leydig cells with volumes 2-3 times larger than those of normal Leydig cells were detected in the mutant mouse testes ( Fig. 3; B 
and E).
Compared with that of the WT cells, the cytoplasm of the knockout Leydig cells stained less uniformly with eosin and contained vacuoles (Fig. 3D) . Hyperplasia occurred more frequently (although not exclusively) in the peripheral space under the testicular capsule (Fig. 3, B and E) , but hypertrophy of Leydig cells was commonly observed within inner tubular junctions (Fig. 3D) . The second abnormality in the knockout testes was the presence of numerous so-called giant yellow cells (Fig. 3, E and F) . These cells contained multiple dark stained nuclei and were detected in the hyperplastic lesions found in the peripheral space (Fig. 3E) as well as in Leydig cell clusters located at inner tubular junctions (Fig. 3F) . In many of the sections, we also noticed a thickening of the capsule of the knockout testis, but this putative phenotype remains to be verified with more objective morphometric analysis. Finally, seminiferous tubule damage was observed in the majority of testis sections of 12-months and older knockout mice. These abnormal tubules were filled with vacuoles and had disrupted spermatogenic epithelium (Fig.  4, A and B ). They were usually localized adjacent to hypertrophic and hyperplastic Leydig cell lesions (Fig. 4, A and B) .
Exogenous estrogen accelerated the development of Leydig cell hypertrophy/hyperplasia and seminiferous tubule damage in knockout mouse
To test the hypothesis that the structural abnormalities in Leydig cells of the older knockout mouse were a result of increased intracrine and paracrine estrogen activity in the absence of EST, exogenous E2 was administered for 3 wk to 2-month-old WT and knockout males to determine whether similar structural lesions could be induced to develop in the testes of younger knockout mice. Treatment with exogenous E2 suppressed spermatogenesis, to some degree, in both genotypes; but, as shown in Fig. 4C , it did not cause appreciable Leydig cell damage in the WT mouse. In contrast, severe Leydig cell hypertrophy/hyperplasia and seminiferous tubule damage were observed in the estrogen-treated knockout mouse testis (Fig. 4D) . Thus, exogenous estrogen accelerated the development of structural lesions in the knockout mouse testis.
Reduced sperm motility and litter size, and other reproductive tract abnormalities in older knockout mice
To further evaluate the long-term consequence of EST deficiency in the male reproductive system, we examined, in addition to testis histology, the sperm motility and general morphology of the male reproductive tracts of 18-to 22-month-old mice and compared them with that of 3-monthold mice. In addition to Leydig cell hypertrophy/hyperplasia and seminiferous tubule damage, as described above, there was also a significant reduction in the relative weights of the testis and epididymis of 18-to 22-month-old knockout mice (organ weight/body weight ϫ 100: testis, 0.63 Ϯ 0.05 for WT, 0.51 Ϯ 0.04 for knockout; epididymis, 0.43 Ϯ 0.06 for WT, 0.31 Ϯ 0.07 for knockout, mean Ϯ sd, P Ͻ 0.05, t test, Fig. 5E ). A most striking abnormality was found with the knockout mouse seminal vesicle/coagulating gland, which had significantly increased wet weight because of tissue swelling [organ weight/body weight ϫ 100: 0.85 Ϯ 0.15 for WT, 1.44 In the first experiment, 5 mating pairs (2 months old) in each genotype were set up, with each male pairing with a female. In the second experiment, 6 WT and 6 knockout (KO) males were mated with WT females, with each male being housed with 4 females. In the third experiment, 15 WT and 15 KO females were mated with wild-type males. The females were housed in 4 cages (4, 4, 4, and 3), and each cage contained 1 male. Ϯ0.47 for knockout, mean Ϯ sd, P Ͻ 0.05, t test ( Fig. 5; A, B , and E)]. Furthermore, although caudal sperm number was not significantly decreased, total and forward motility of sperm isolated from caudal epididymis of 18-to 22-monthold knockout mice were reduced by 60% and 80%, respectively (Fig. 5F ). In contrast, the reproductive tracts of 3-month-old knockout mice were largely normal (organ weight/body weight ϫ 100: testis, 0.81 Ϯ 0.03 for WT, 0.70 Ϯ 0.05 for knockout; epididymis, 0.45 Ϯ 0.05 for WT, 0.41 Ϯ 0.07 for knockout; seminal vesicle/coagulating gland, 1.04 Ϯ 0.15 for WT, 1.09 Ϯ 0.11 for knockout; mean Ϯ sd, Fig. 5C ), and there was no reduction in sperm total or forward motility in these younger knockout mice (Fig. 5D) . To assess whether the reduced motility of caudal sperm from the older knockout males is associated with reduced fertility, a controlled mating experiment was conducted in which five 17-to 18-month-old WT or knockout males were mated with 8-wk-old WT females. During a 2-month period, the knockout males sired a number of litters similar to that of the WT mice. However, the litter size in the knockout group was significantly smaller ( Table 2) .
Discussion
In this study, we have taken a gene knockout approach to assess the physiological role of EST in intracrine and paracine estrogen regulation. Inactivation of the mouse EST gene was confirmed by the absence, in the mutant mouse testes, of detectable EST mRNA and protein and by the lack of EST activity in the testis homogenate. The fact that no anomalous EST mRNA or protein was detected in the mutant mouse indicated that insertion of neo into exon III caused a null mutation, probably by destabilization of the EST mRNA. EST knockout mice were born with the expected frequency and sex ratio and developed normally to sexual maturity. This outcome is consistent with our previous finding that EST is not expressed in the fetal or immature mouse testis (11) and, therefore, is not expected to be involved in fetal development or sex determination.
Except for a small decrease in testicular weights (Fig. 5C ), the reproductive system of younger (3-6 months) knockout male mice appeared normal, both structurally and functionally. Serum T and E2 levels in the knockout males were in the normal range. Although we initially found a reduction in the fertility of the knockout mice, subsequent cross-breeding experiments suggested that the impairment most likely lay with the female knockout mice. The conclusion that younger knockout males had normal fertility is consistent with the result of sperm motility assays, which detected no abnormality in the knockout males of this age group (Fig. 5D) . The nature of the female reproductive defect in the EST knockout mice remains to be characterized; but we recently have discovered that, in addition to Leydig cells of the testis, EST is also expressed in late stages of the mouse placenta and uterus (our unpublished observations).
Interestingly, as mice aged, EST knockout mice were found to develop with high-incidence Leydig cell hypertrophy/hyperplasia and seminiferous tubule damage. The time-dependent nature in the development of these structural lesions suggested that the damaging effect of EST de- and seminal vesicle/coagulating gland (Sem. Ves.)] and caudal sperm motility were determined for 3-month-old (n ϭ 5 for WT, n ϭ 7 for knockout) and 18-to 20-month-old male mice (n ϭ 6 for both WT and knockout). In the case of 3-month-old knockout mice, only the testis weight is significantly different from that of the WT mice (P Ͻ 0.05, t test, C and D). In contrast, 18-to 20-month-old knockout mice had significantly increased seminal vesicle/coagulating gland weight because of tissue swelling and significantly decreased testis and epididymal weights (E, P Ͻ 0.05), as well as significantly reduced sperm total and forward motility (F, P Ͻ 0.01). A and B show gross morphology of representative seminal vesicle/coagulating glands from a 20-month-old WT (A) and an age-matched knockout mouse (B). ficiency is chronic and progressive. In theory, these Leydig cell abnormalities could result from changes in the hypothalamus-pituitary-testis axis or from increased intracrine estrogen stimulation in the absence of intracellular EST. Because EST is not expressed in the mouse brain (10) and serum steroid levels were normal in the knockout mice, the most likely explanation for this phenotype is increased intracrine estrogen stimulation, rather than systemic hormonal disturbance. Consistent with this hypothesis, administration of exogenous E2 caused no visible Leydig cell abnormalities in the WT mice but induced highly similar structural lesions in the testes of younger knockout mice. This differential response by the knockout Leydig cells contrasted with spermatogenesis suppression, which occurred, to a similar degree, in the WT and knockout mice and which was likely attributable to the systemic effect of estrogen involving the hypothalamus-pituitary-testis axis (29) . However, the possibility cannot be excluded that knockout Leydig cells had altered sensitivity to gonadotropin disturbances caused by E2 administration. On the other hand, it is well known that Leydig cells not only produce estrogen (13, 30) but also are targets of direct estrogen stimulation. For example, estrogen receptors have been detected in both the human and mouse Leydig cells (31, 32) , and ectopic exogenous E2 has been shown to cause Leydig cell tumors in susceptible strains of mice (33, 34) . Two conspicuous features of the Leydig cell abnormality in the knockout mice were noticed and remain to be explained mechanistically. The first is that the hypertrophic/ hyperplastic Leydig cell masses were more frequently localized in the peripheral space under the testicular capsule. This suggests that either Leydig cells localized in these regions were phenotypically different (i.e. more responsive to estrogen stimulation) from those residing in the inner areas of the testis, or that there were important paracrine factors released from other cell types nearby (e.g. stroma cells under the capsule) that acted in concert with estrogen to cause Leydig cell proliferation. A second conspicuous feature concerning the knockout Leydig cells is the presence of multinucleated giant yellow cells in the interstitial space and the hyperplastic lesions. The identity of these cells is not yet known. It is possible that these cells were estrogen-stimulated Leydig cells that had undergone repeated, but incomplete, mitogenesis. Alternatively, they may represent a subclass of testicular macrophages undergoing active phagocytosis of damaged Leydig cells.
Because EST is not expressed in the seminiferous tubules (11), the disruption of tubular structure in older EST knockout mice is likely a result of altered paracrine stimulation. Changes in paracrine stimulation may be caused by increased paracrine estrogen activity. Additionally, the hypertrophic/hyperplastic Leydig cells may also release other nonsteroidal paracrine factors (35) that could negatively impact the local microenvironment and ultimately contribute to the development of a seminiferous tubule defect. This scenario was supported by the fact that abnormal tubular segments were mostly observed in areas immediately adjacent to the hyperplastic Leydig cell lesions (Fig. 4A) . A similar paracrine effect of unmetabolized estrogen originating from the testis may account for the structural and functional abnormalities observed in the seminal vesicle and epididymis in older knockout mice, although potential localized expression of EST in various accessory organs at different developmental stages remains to be examined in detail. The effect of estrogen on the accessory structures of the male reproductive tract of the mouse has been demonstrated in other studies and is known to be mediated by estrogen receptor (20 -22, 36) .
In summary, we have described a number of age-dependent abnormalities in the male reproductive system of EST knockout mice. These observations provide direct evidence for a physiological role of estrogen metabolism in intracrine and paracrine regulation of estrogen activity. They also shed new light on the biology of estrogen in the male reproductive system of mammals. There is now little doubt that estrogen is required for normal testicular function, as has been demonstrated by recent studies of estrogen receptor ␣ and P450 aromatase gene knockout mice (19, 20, (37) (38) (39) . The present study indicates that, whereas estrogen is required in the testis, there is also a physiological need to maintain proper intracrine and paracrine estrogen homeostasis in the male reproductive tract. Our results further imply that inhibition of estrogen transformation enzymes, such as EST, as has been demonstrated recently for human EST with several common environmental chemicals (23, 24) , may constitute a novel mechanism of endocrine disruption by environmental chemicals that is independent of their direct interaction with the estrogen receptors.
